NFKB1 and Miyoshi myopathy: We therefore performed NFκB STA analysis on dataset GSE68871 that contains CD138-purified samples of newly diagnosed MM patients which were subsequently treated with first-line VTD (bortezomib-thalidomide-dexamethasone) induction therapy.